FDA Stalls Ruling on 'Plan B' Pill
The Food and Drug Administration's decision to delay a ruling on whether to approve the so-called 'morning after' pill for sale without a prescription prompts an outcry. An agency panel has given the planned over-the-counter sales overwhelming support. Backers of the pill say politics are interfering with science. NPR's Julie Rovner reports.
Comments
Discussions for this story are now closed. Please see the Community FAQ for more information.